Evidence map›Paper›PMID 17355249›Full record

ArticleClinical and experimental immunology2007

Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease.

C W O Ernst, J E Lee, T Nakanishi, N Y Karimbux, T M B Rezende, P Stashenko, M Seki, M A Taubman, T Kawai

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. FOXP3+ T Cells-An Emerging Evidence in Periodontitis Therapeutics.Clinical and experimental dental research · 2025
    Review
  6. Role of regulatory immune cells in pathogenesis and therapy of periodontitis.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Association betweenFrontiers in cellular and infection microbiology · 2022
    Review
  12. Review
  13. Review
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis.Advances in protein chemistry and structural biology · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

C W O ErnstDepartment of Immunology, The Forsyth Institute, Boston, MA 02115, USA.
J E Lee
T Nakanishi
N Y Karimbux
T M B Rezende
P Stashenko
M Seki
M A Taubman
T Kawai
Harvard University · US

Funding

REGULATORY CELLS IN EXPERIMENTAL PERIODONTAL DISEASER01DE003420 · NIDCR · FORSYTH INSTITUTE · PI KAWAI, TOSHIHISA · 1985 to 2012
$4.3M
REGULATION OF BONE DESTRUCTION IN PERIAPICAL LESIONSR01DE009018 · NIDCR · FORSYTH INSTITUTE · PI STASHENKO, PHILIP · 1989 to 2005
$1.5M
Tolerance to Oral Bacteria in Periodontal InflammationK22DE014551 · NIDCR · FORSYTH INSTITUTE · PI KAWAI, TOSHIHISA · 2002 to 2005
$541k
REGULATORY CELLS IN EXPERIMENTAL PERIODONTAL DISEASER37DE003420 · NIDCR · FORSYTH INSTITUTE · PI TAUBMAN, MARTIN A · 1990 to 1999
–
NIDCR NIH HHS DE-03420NIDCR NIH HHS DE-09018NIDCR NIH HHS DE-14551NIDCR NIH HHS K22 DE014551NIDCR NIH HHS R01 DE003420NIDCR NIH HHS R01 DE009018NIDCR NIH HHS R37 DE003420
6 · The paper itself

Abstract

Periodontal disease involves multi-bacterial infections accompanied by inflammatory bone resorption lesions. The abundant T and B lymphocyte infiltrates are the major sources of the osteoclast differentiation factor, receptor activator for nuclear factor-kappaB ligand (RANKL) which, in turn, contributes to the development of bone resorption in periodontal disease. In the present study, we found that the concentrations of RANKL and regulatory T cell (T(reg))-associated cytokine, interleukin (IL)-10, in the periodontal tissue homogenates were correlated negatively, whereas RANKL and proinflammatory cytokine, IL-1beta, showed positive correlation. Also, according to the fluorescent-immunohistochemistry, the frequency of forkhead box P3 (FoxP3)/CD25 double-positive cells was diminished strikingly in the bone resorption lesion of periodontal disease compared to healthy gingival tissue, while CD25 or FoxP3 single positive cells were still observed in lesions where abundant RANKL+ lymphocytes were present. Very importantly, few or no expressions of FoxP3 by the RANKL+ lymphocytes were observed in the diseased periodontal tissues. Finally, IL-10 suppressed both soluble RANKL (sRANKL) and membrane RANKL (mRANKL) expression by peripheral blood mononuclear cells (PBMC) activated in vitro in a bacterial antigen-specific manner. Taken together, these results suggested that FoxP3/CD25 double-positive T(reg) cells may play a role in the down-regulation of RANKL expression by activated lymphocytes in periodontal diseased tissues. This leads to the conclusion that the phenomenon of diminished CD25+FoxP3+ T(reg) cells appears to be associated with the increased RANKL+ T cells in the bone resorption lesion of periodontal disease.

Indexed as

AdultBone ResorptionCells, CulturedFemaleForkhead Transcription FactorsGingivaHumansInterleukin-10Interleukin-1betaInterleukin-2 Receptor alpha SubunitLymphocyte ActivationMaleMicroscopy, ConfocalPeriodontal DiseasesRANK LigandT-Lymphocytes, RegulatoryForkhead Transcription FactorsFOXP3 protein, humanInterleukin-10Interleukin-1betaInterleukin-2 Receptor alpha SubunitRANK LigandTNFSF11 protein, human

Identifiers

PMID17355249
PMCPMC1868884
OpenAlexW2067981232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.